By Priscila Mayumi Kashiwabara
9 de September de 2024
Kasznar Leonardos wins LMG Life Sciences
We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences!
This prestigious award is intended for firms and professionals working in regulatory, corporate, Intellectual Property, and litigation within the Life Sciences sector.
This year’s edition marks Brazil’s debut in the awards, and we have been elected as the winner of the best Brazilian Firm. LMG also recognizes firms and names from markets in the northern hemisphere.
A recognition like LMG reflects the quality of our services and the expertise of our professionals. We congratulate the team, led by partner Priscila Kashiwabara and formed by technical specialists Marisa Momoli, Breno Alves, Lívia Figueiredo, Gabriel da Fonseca Cavalcante, Luan Pinto and Juliana Marinho.
We are thrilled to be considered a reference in Brazil in the Life Sciences area!
Last by Priscila Mayumi Kashiwabara
25 de August de 2026
Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project
On August 25, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of a Collaborative Patent Application Examination Project in … Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project
14 de August de 2026
INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed … INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
1 de July de 2026
INPI Ordinance No. 80/2026 and Second Medical Use Patents
INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents